Acessibilidade / Reportar erro

Number of COVID-19 patients classified as cured: an imminent danger for the population

Dear Editor,

Several studies have been carried out and highlighted the severity of many cases of the coronavirus disease 2019 (COVID-19).(11. Teich VD, Klajner S, Almeida FA, Dantas AC, Laselva CR, Torritesi MG, et al. Epidemiologic and clinical features of patients with COVID-19 in Brazil. einstein (São Paulo). 2020;18:eAO6022.33. Savioli F. Is there a rationale for heparin use among severe COVID-19 patients? einstein (São Paulo). 2020; 18:eED5758.) Nonetheless, the criteria that have been adopted so far by many countries, such as Brazil, for progression to cure of patients with mild symptoms or asymptomatic individuals, may pose risks due to some limitations in monitoring the evolution of the infection. In such situations, the current recommendation includes laboratory tests to confirm cure only in the severe cases of the disease. For asymptomatic patients or those with mild symptoms, even with laboratory confirmation for the initial diagnosis, most will follow only the clinical criteria to establish a final classification of cure, which is generally based on reports of patients.(44. Lisboa V. Agência Brasil explica: quando alguém é considerado curado da Covid-19. Entenda critérios e avaliações envolvidos na recuperação de infectados [Internet]. Rio de Janeiro (RJ): Agência Brasil; 2020 [citado 2020 Ago 15]. Disponível em: https://agenciabrasil.ebc.com.br/saude/noticia/2020-05/agencia-brasilexplica-quando-alguem-e-considerado-curado-da-covid-19
https://agenciabrasil.ebc.com.br/saude/n...
) Considering the possibility of intermittent or persistent symptoms in patients who had mild symptoms for over 14 days,(55. Abdulamir AS, Hafidh RR. The possible immunological pathways for the variable immunopathogenesis of COVID-19 infections among healthy adults, elderly and children. Electron J Gen Med. 2020;17(4):em202.) and the impracticability of providing appropriate clinical criteria to assess the asymptomatic cases, the number of cured individuals may be considerably overestimated worldwide. In addition, asymptomatic individuals who are not cured yet may resume their work and routine activities, placing a large proportion of the population at risk.

REFERENCES

  • 1
    Teich VD, Klajner S, Almeida FA, Dantas AC, Laselva CR, Torritesi MG, et al. Epidemiologic and clinical features of patients with COVID-19 in Brazil. einstein (São Paulo). 2020;18:eAO6022.
  • 2
    Santacroce L, Charitos IA, Del Prete R. COVID-19 in Italy: an overview from the first case to date. Electron J Gen Med. 2020;17(6):em235.
  • 3
    Savioli F. Is there a rationale for heparin use among severe COVID-19 patients? einstein (São Paulo). 2020; 18:eED5758.
  • 4
    Lisboa V. Agência Brasil explica: quando alguém é considerado curado da Covid-19. Entenda critérios e avaliações envolvidos na recuperação de infectados [Internet]. Rio de Janeiro (RJ): Agência Brasil; 2020 [citado 2020 Ago 15]. Disponível em: https://agenciabrasil.ebc.com.br/saude/noticia/2020-05/agencia-brasilexplica-quando-alguem-e-considerado-curado-da-covid-19
    » https://agenciabrasil.ebc.com.br/saude/noticia/2020-05/agencia-brasilexplica-quando-alguem-e-considerado-curado-da-covid-19
  • 5
    Abdulamir AS, Hafidh RR. The possible immunological pathways for the variable immunopathogenesis of COVID-19 infections among healthy adults, elderly and children. Electron J Gen Med. 2020;17(4):em202.

Publication Dates

  • Publication in this collection
    23 Oct 2020
  • Date of issue
    2020

History

  • Received
    29 Aug 2020
  • Accepted
    22 Sept 2020
Instituto Israelita de Ensino e Pesquisa Albert Einstein Avenida Albert Einstein, 627/701 , 05651-901 São Paulo - SP, Tel.: (55 11) 2151 0904 - São Paulo - SP - Brazil
E-mail: revista@einstein.br